tiprankstipranks
3D Medicines, Inc. (HK:1244)
:1244
Hong Kong Market
1244
3D Medicines, Inc.
RESEARCH TOOLSreports

3D Medicines, Inc. (1244) Stock News & Sentiment

2 Followers
3D Medicines Extends HK$50 Million Note to Puxin, Flags Disclosure Lapse
Premium
Company Announcements
3D Medicines Extends HK$50 Million Note to Puxin, Flags Disclosure Lapse
13d ago
1244
3D Medicines Advances Oncology Platforms Despite Envafolimab Revenue Dip in 2025
Premium
Company Announcements
3D Medicines Advances Oncology Platforms Despite Envafolimab Revenue Dip in 2025
13d ago
1244
3D Medicines Sets March 31 Board Meeting to Approve 2025 Results and Mull Dividend
Premium
Company Announcements
3D Medicines Sets March 31 Board Meeting to Approve 2025 Results and Mull Dividend
26d ago
1244
3D Medicines Moves Envafolimab Toward Full Approval in China
Premium
Company Announcements
3D Medicines Moves Envafolimab Toward Full Approval in China
2M ago
1244
3D Medicines Appoints Veteran Capital Markets Executive as New CFO
Premium
Company Announcements
3D Medicines Appoints Veteran Capital Markets Executive as New CFO
3M ago
1244
3D Medicines’ Envafolimab NDA for First-Line Biliary Tract Cancer Accepted by China’s NMPA
Premium
Company Announcements
3D Medicines’ Envafolimab NDA for First-Line Biliary Tract Cancer Accepted by China’s NMPA
3M ago
1244
3D Medicines Wins Third Orphan-Drug Designation for Envafolimab in Gastric Cancers
Premium
Company Announcements
3D Medicines Wins Third Orphan-Drug Designation for Envafolimab in Gastric Cancers
4M ago
1244
More HK:1244 News >

1244 News on the Web

3D Medicines Extends HK$50 Million Note to Puxin, Flags Disclosure Lapse
TipRanks News
Neutral
3D Medicines Advances Oncology Platforms Despite Envafolimab Revenue Dip in 2025
TipRanks News
Neutral
3D Medicines Sets March 31 Board Meeting to Approve 2025 Results and Mull Dividend
TipRanks News
Neutral
3D Medicines Moves Envafolimab Toward Full Approval in China
TipRanks News
Bullish
3D Medicines Appoints Veteran Capital Markets Executive as New CFO
TipRanks News
Neutral
3D Medicines’ Envafolimab NDA for First-Line Biliary Tract Cancer Accepted by China’s NMPA
TipRanks News
Bullish
3D Medicines Wins Third Orphan-Drug Designation for Envafolimab in Gastric Cancers
TipRanks News
Neutral
3D Medicines, Inc. Enhances Operational Stability Through Strategic Cooperation
TipRanks News
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is HK:1244’s Media Buzz Sentiment?
Currently, no data Available
What is HK:1244’s weekly average amount of articles?
Currently, no data Available
What is HK:1244’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
TXTMProText Mobility
STAAStaar Surgical
ALLOAllogene Therapeutics
REPLReplimune Group
IVVDInvivyd
Showing the stocks with the most bullish news sentiment over the past week